Text Messaging Support for Patients Diagnosed With Impaired Glucose Tolerance During Pregnancy: Nonrandomized Pre-Post Implementation Study Assessing Impact on Postpartum Transitions of Care - Report - MDSpire

Text Messaging Support for Patients Diagnosed With Impaired Glucose Tolerance During Pregnancy: Nonrandomized Pre-Post Implementation Study Assessing Impact on Postpartum Transitions of Care

  • By

  • Natasha R Kumar

  • Whitney Bender

  • Celeste Durnwald

  • June 9, 2026

  • 0 min

Share

Support via Text Messaging for Pregnant Patients with Impaired Glucose Tolerance

Overview

Revise to focus solely on the evaluation of the BRIDGE program without conclusions.

Background

Remove claims about effective interventions and focus on the lack of guidelines.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

  • Approximately 1 in 3 American adults has impaired glucose tolerance (IGT).
  • Up to 70% of patients with IGT may develop diabetes without intervention.
  • Patients with IGT are at risk for adverse pregnancy outcomes, including spontaneous preterm birth.
  • 71% of patients with IGT did not have a visit with a primary care provider within 1 to 3 years after delivery.
  • 93.3% of patients who completed repeat HbA1c testing remained above the threshold for IGT 1 to 3 years postpartum.

Clinical Implications

Healthcare providers should consider implementing structured support programs like BRIDGE to enhance follow-up care for patients with IGT during and after pregnancy. Addressing gaps in care can potentially improve long-term health outcomes for these patients.

Conclusion

The BRIDGE program highlights the importance of structured support in managing postpartum transitions for patients with IGT. Further evaluation of such interventions is warranted to optimize care pathways.

Related Resources & Content

  1. American Diabetes Association, Diabetes Care, 2026 -- Management of Diabetes in Pregnancy: Standards of Care in Diabetes
  2. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Utilizing Diabetes Technology for Managing Pregnant Patients with Diabetes
  3. The Journal of Clinical Endocrinology & Metabolism, 2024 -- Evaluating the Feasibility of a Low-Intensity Dietary Approach to Lower Triglycerides in Gestational Diabetes: A Randomized Controlled Trial
  4. conexiant, 2023 -- CGM in Early Gestational Diabetes Improved Outcomes
  5. The Journal of Clinical Endocrinology & Metabolism — Comparative Analysis of Early Intervention and Monitoring in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  6. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
  7. Untitled

Original Source(s)

Text Messaging Support for Patients Diagnosed With Impaired Glucose Tolerance During Pregnancy: Nonrandomized Pre-Post Implementation Study Assessing Impact on Postpartum Transitions of Care

  • by Natasha R Kumar, Whitney Bender, Celeste Durnwald

  • June 9, 2026

Related Content

Associations between adjuvant antibiotic therapy and fistula formation after incision and drainage of anorectal abscesses: results from a retrospective cohort study

Use of Preventive Measures for Cardiovascular Disease in People With HIV

Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study